Creation of a genetic calcium channel blocker by targeted Gem gene transfer in the heart

Mitsushige Murata, Eugenio Cingolani, Amy D. McDonald, J. Kevin Donahue, Eduardo Marbán

研究成果: Article査読

83 被引用数 (Scopus)


Calcium channel blockers are among the most commonly used therapeutic drugs. Nevertheless, the utility of calcium channel blockers for heart disease is limited because of the potent vasodilatory effect that causes hypotension, and other side effects attributable to blockade of noncardiac channels. Therefore, focal calcium channel blockade by gene transfer is highly desirable. With a view to creating a focally applicable genetic calcium channel blocker, we overexpressed the ras-related small G-protein Gem in the heart by somatic gene transfer. Adenovirus-mediated delivery of Gem markedly decreased L-type calcium current density in ventricular myocytes, resulting in the abbreviation of action potential duration. Furthermore, transduction of Gem resulted in a significant shortening of the electrocardiographic QTc interval and reduction of left ventricular systolic function. Focal delivery of Gem to the atrioventricular (AV) node significantly slowed AV nodal conduction (prolongation of PR and AH intervals), which was effective in the reduction of heart rate during atrial fibrillation. Thus, these results indicate that gene transfer of Gem functions as a genetic calcium channel blocker, the local application of which can effectively modulate cardiac electrical and contractile function.

ジャーナルCirculation research
出版ステータスPublished - 2004 8月 20

ASJC Scopus subject areas

  • 生理学
  • 循環器および心血管医学


「Creation of a genetic calcium channel blocker by targeted Gem gene transfer in the heart」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。